To define the prevalence of neuromuscular, musculoskeletal, visceral, oncologic, and other late effects affecting function and quality of life (QOL)...

In summary, our study contributes to growing evidence suggesting that high BMI or obesity may be a risk factor for progression from MGUS to MM...

Our findings suggest that multiple myeloma patients with double/triple hit cytogenetics on FISH have aggressive presentations, high early mortality...

NGS approaches should be considered as a replacement technique for a more comprehensive evaluation of the multiple myeloma clone

PLR was a robust prognostic factor for newly diagnosed early-stage cHL

We conclude that MM survivors who achieve disease control after AHCT have excellent recovery of FACT-BMT and subscale scores to population norms by 1...

CD138+ overexpression of miR-181a was strongly correlated with inferior disease outcome and contributed to superior prediction of MM patients early...

These findings demonstrate the existence of a complex immunoregulatory microenvironment in CTCL and support the development of immunotherapies...

The subtype and SMN risk among Hodgkin lymphoma survivors varied by race/ethnicity

Our findings highlight the need for prospective studies to examine tumour and host biology, and to test novel therapies across the age spectrum

The frequency of morbid versus asymptomatic PD and its effect on survival is unknown

We find that patients with CTCL are at increased risk of second malignancies, especially Hodgkin and non-Hodgkin lymphoma, lung cancer, bladder cancer...